American Century Companies’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
HA
TCM
American Century Companies's CTKB Position: Q2 2026 in Review
American Century Companies increased its Cytek Biosciences (CTKB) stake by 3.7% in Q2 2026, buying an estimated $44.5K and bringing the position to 292,103 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2334.
American Century Companies first reported a position in CTKB in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.44M in Q4 2025. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.
- American Century Companies held 292,103 shares of Cytek Biosciences worth $1.29M as of Q2 2026.
- American Century Companies bought 10,422 Cytek Biosciences shares in Q2 2026, an estimated $44.5K.
- Cytek Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2334 holding.
- American Century Companies first reported a position in Cytek Biosciences in Q4 2023 and has held it in 11 quarters since.
- American Century Companies's Cytek Biosciences position peaked at $1.44M in Q4 2025.
- 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.